Ixekizumab Subcutaneous and Recombinate recombinant
Determining the interaction of Ixekizumab Subcutaneous and Recombinate recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ixekizumab
Brand name: Taltz Autoinjector, Taltz Prefilled Syringe
Synonyms: Ixekizumab
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant), Recombinate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ixekizumab Subcutaneous-Recombivax
- Ixekizumab Subcutaneous-Recombivax HB
- Ixekizumab Subcutaneous-Recombivax HB Adult
- Ixekizumab Subcutaneous-Recombivax HB Dialysis Formulation
- Ixekizumab Subcutaneous-Recombivax HB Pediatric/Adolescent
- Ixekizumab Subcutaneous-Recort Plus
- Recombinate recombinant-Ixempra
- Recombinate recombinant-Ixempra Kit
- Recombinate recombinant-Ixiaro
- Recombinate recombinant-Ixifi Intravenous
- Recombinate recombinant-Ixinity
- Recombinate recombinant-Ixinity Intravenous